CVE-2023-38950: ZKTeco BioTime Path Traversal
ZKTeco BioTime · listed in the CISA catalog of actively exploited vulnerabilities since 2025-05-19.
- CVSS v3.1 (CISA ADP)
- 7.5
- high
- EPSS (exploit probability, 30 days)
- 92%
- higher than 99.8% of all CVEs
- Added to CISA KEV
- 2025-05-19
- US federal due date 2025-06-09
- Automatable (CISA SSVC)
- yes
- technical impact: partial
What is CVE-2023-38950?
A path traversal vulnerability in the iclock API of ZKTeco BioTime v8.5.5 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload. This vulnerability was fixed in version 9.0.120240617.19506 of ZKBioTime.
CISA required action: Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.
CISA notes
How to fix it
- The CVE record names no fixed version – check the vendor advisory and CISA's required action for updates and mitigations.
- Vendor advisory: zkteco.com/en/Security_Bulletinsibs
- CISA's deadline for US federal agencies: 2025-06-09 (passed) – a useful benchmark for everyone else, too.
CISA's assessment (SSVC)
- Exploitation
- Exploited in the wild
- Automatable
- Yes – attackers can automate it at scale
- Technical impact
- Partial – limited control or information
Weakness: CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
References
Other advisories
Trackers and catalogs
Data: CISA Known Exploited Vulnerabilities (public domain) · CVE Program records incl. CISA ADP enrichment · OSV.dev (CC BY 4.0) incl. Ubuntu and Debian security data · FIRST EPSS · endoflife.date. Updated automatically – facts last changed 2026-11-21. Always confirm with the vendor's or distribution's advisory before patching.